Cover Image
市場調查報告書

牙科生技材料:開發平台分析

Dental Biomaterials - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 344642
出版日期 內容資訊 英文 136 Pages
訂單完成後即時交付
價格
Back to Top
牙科生技材料:開發平台分析 Dental Biomaterials - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年12月01日 內容資訊: 英文 136 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的牙科生技材料 (生物材料) 之開發中產品資訊相關分析,提供您臨床實驗/產品開發的整體進展,及各階段·各領域·各地區的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發的動向·產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 牙科生技材料:現在正在開發的開發中產品 (各企業)

  • 牙科生技材料的開發企業:開發中產品 (各開發階段)
  • 牙科生技材料:各開發階段的開發中產品一覽

第5章 牙科生技材料的企業·產品概要

  • three·D·矩陣
    • 開發中產品及現在進行中的臨床實驗概要
  • Advanced Medical Solutions Group plc
  • botiss dental GmbH
  • CollPlant Ltd.
  • CoreBone Ltd.
  • Harvard University
  • Histocell S.L.
  • Ironwood Material Science Inc
  • Lacerta Technologies GmbH
  • Maxigen Biotech Inc.
  • Medisse BV
  • Medtronic plc
  • Meta Biomed Co., Ltd.
  • NDSU Research Foundation
  • Noraker
  • NovaBone Products, LLC.
  • Novatissue SAS
  • REGENECURE, Ltd.
  • Straumann Holding AG
  • SurgaColl Technologies Ltd
  • The University of Queensland
  • Tigran Technologies AB
  • Universitat Politecnica de Catalunya
  • University of Strasbourg

第6章 牙科生技材料:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0263EPD

GlobalData's Medical Devices sector report, "Dental Biomaterials - Medical Devices Pipeline Assessment, 2016" provides an overview of Dental Biomaterials currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dental Biomaterials pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Dental Biomaterials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dental Biomaterials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dental Biomaterials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Dental Biomaterials Overview 10

3 Products under Development 11

  • 3.1 Dental Biomaterials - Pipeline Products by Stage of Development 11
  • 3.2 Dental Biomaterials - Pipeline Products by Segment 12
  • 3.3 Dental Biomaterials - Pipeline Products by Territory 13
  • 3.4 Dental Biomaterials - Pipeline Products by Regulatory Path 14
  • 3.5 Dental Biomaterials - Pipeline Products by Estimated Approval Date 15
  • 3.6 Dental Biomaterials - Ongoing Clinical Trials 16

4 Dental Biomaterials - Pipeline Products under Development by Companies 17

  • 4.1 Dental Biomaterials Companies - Pipeline Products by Stage of Development 17
  • 4.2 Dental Biomaterials - Pipeline Products by Stage of Development 19

5 Dental Biomaterials Companies and Product Overview 21

  • 5.1 3-D Matrix Ltd Company Overview 21
    • 5.1.1 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.2 Advanced Medical Solutions Group plc Company Overview 23
    • 5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.3 botiss dental GmbH Company Overview 28
    • 5.3.1 botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.4 CoreBone Ltd. Company Overview 36
    • 5.4.1 CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.5 credentis AG Company Overview 37
    • 5.5.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.6 curasan AG Company Overview 38
    • 5.6.1 curasan AG Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.7 Daewoong Pharmaceutical Co Ltd Company Overview 40
    • 5.7.1 Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.8 Datum Dental Ltd Company Overview 42
    • 5.8.1 Datum Dental Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.9 Harvard University Company Overview 44
    • 5.9.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.10 Histocell SL Company Overview 45
    • 5.10.1 Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.11 Ironwood Material Science Inc Company Overview 46
    • 5.11.1 Ironwood Material Science Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.12 Maxigen Biotech Inc Company Overview 47
    • 5.12.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.13 Medisse BV Company Overview 49
    • 5.13.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.14 Medtronic plc Company Overview 50
    • 5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.15 Meta Biomed Co Ltd Company Overview 52
    • 5.15.1 Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.16 NDSU Research Foundation Company Overview 55
    • 5.16.1 NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.17 Nobel Biocare Holding AG Company Overview 56
    • 5.17.1 Nobel Biocare Holding AG Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.18 NovaBone Products LLC Company Overview 57
    • 5.18.1 NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.19 Novatissue SAS Company Overview 58
    • 5.19.1 Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.20 Orthocell Limited Company Overview 59
    • 5.20.1 Orthocell Limited Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.21 PolyPid Ltd Company Overview 61
    • 5.21.1 PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.22 REGENECURE, Ltd. Company Overview 65
    • 5.22.1 REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.23 Straumann Holding AG Company Overview 68
    • 5.23.1 Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.24 SurgaColl Technologies Ltd Company Overview 70
    • 5.24.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.25 SweetBio, Inc. Company Overview 71
    • 5.25.1 SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.26 The University of Queensland Company Overview 72
    • 5.26.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.27 Tigran Technologies AB Company Overview 73
    • 5.27.1 Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.28 Universitat Politecnica de Catalunya Company Overview 74
    • 5.28.1 Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.29 University of Strasbourg Company Overview 76
    • 5.29.1 University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview 76

6 Dental Biomaterials- Recent Developments 77

  • 6.1 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 77
  • 6.2 Nov 10, 2016: Curasan Continues Dynamic Growth in the Third Quarter 77
  • 6.3 Nov 04, 2016: Dentsply Sirona Reports Third Quarter 2016 Results 78
  • 6.4 Nov 03, 2016: DSM Q3 2016 Results 79
  • 6.5 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 81
  • 6.6 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. 82
  • 6.7 Oct 27, 2016: Karolinska Development Portfolio Company Promimic Appoints New Chairman and Directors to its Board 83
  • 6.8 Oct 27, 2016: Stryker reports third quarter 2016 results 83
  • 6.9 Oct 27, 2016: Another Strong Quarter (+13% Organic) Keeps Straumann On Track To Achieve Full-Year Targets 84
  • 6.10 Oct 24, 2016: Philips' Third Quarter Results 2016 87
  • 6.11 Oct 21, 2016: Modern Dental Acquires MicroDental Labs from Healthpointcapital 89
  • 6.12 Oct 19, 2016: Karolinska Development portfolio company Promimic and Danco announce completion of US production line for HAnano Surface medical implant coating 89
  • 6.13 Sep 28, 2016: Glidewell Laboratories Launches Newport Biologics Line of Regenerative Materials 89
  • 6.14 Sep 19, 2016: Organogenesis Announces New Chief Financial Officer 90
  • 6.15 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 90
  • 6.16 Sep 14, 2016: Advanced Medical Solutions Group: Interim Results for the six months ended 30 June 2016 91
  • 6.17 Sep 13, 2016: Promimic Raises USD3.2 Million in Venture Financing 99
  • 6.18 Sep 01, 2016: Philips appoints Sophie Bechu as Chief of Operations 99
  • 6.19 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 99
  • 6.20 Aug 23, 2016: Strong Performance Continues As Organic Growth Of 14% Lifts First-Half Revenue To Record Level 102
  • 6.21 Aug 23, 2016: Straumann reports strong performance continues as organic growth of 14% lifts first-half revenue to record level 106
  • 6.22 Aug 18, 2016: curasan accelerates sales growth in the first six months due to rising foreign demand 111
  • 6.23 Aug 16, 2016: NovaBone Products Receives GMP Medical Device Certificate 111
  • 6.24 Aug 05, 2016: Dentsply Sirona Reports Second Quarter 2016 Results 112
  • 6.25 Aug 01, 2016: Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26 113
  • 6.26 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 114
  • 6.27 Jul 25, 2016: Philips' Second Quarter Results 2016 115
  • 6.28 Jul 21, 2016: Stryker reports second quarter 2016 results 116
  • 6.29 Jul 18, 2016: Straumann takes over distribution of botiss products in Germany 117
  • 6.30 Jul 14, 2016: Straumann to Acquire Controlling Stake in MegaGen 118
  • 6.31 Jul 12, 2016: Philips and Spanish hospital Campus de la Salud start implementation of multi-year strategic partnership agreement 118
  • 6.32 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 118
  • 6.33 Jun 29, 2016: BoneAlbumin Induces Better Bone Formation 119
  • 6.34 Jun 27, 2016: Dentsply Sirona to Acquire MIS Implants Technologies for USD375 Million 119
  • 6.35 Jun 24, 2016: Collagen Matrix Names Bill Messer as Vice President, Sales and Marketing 119
  • 6.36 Jun 14, 2016: Credentis presents first data for periodontitis treatment with CUROLOX TECHNOLOGY 120
  • 6.37 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 120
  • 6.38 Jun 08, 2016: First Future Health Index reveals developed markets have better access to healthcare, but emerging markets lead in adoption of connected technologies 120
  • 6.39 Jun 07, 2016: Zimmer Biomet Plans to Raise USD750 Million in Public Offering of Notes 121
  • 6.40 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 122
  • 6.41 Jun 03, 2016: Philips empowers patients, care teams and health systems through connected solutions for personal and population health at eHealth Week 2016 122
  • 6.42 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 124
  • 6.43 May 23, 2016: Straumann Announces Change In Board Of Directors And Compensation Committee 126
  • 6.44 May 17, 2016: Geistlich Bio-Oss Portfolio Expands 126
  • 6.45 May 12, 2016: Philips Annual General Meeting of Shareholders approves re-appointment of Neelam Dhawan as member of the Supervisory Board 127
  • 6.46 May 11, 2016: curasan posts sales growth in the first quarter 127
  • 6.47 May 03, 2016: Straumann Emdogain launched in new wound-healing indication 128
  • 6.48 May 03, 2016: Straumann reports strong start to the year with organic revenue growth of 12% in Q1 128
  • 6.49 Apr 28, 2016: Curasan: Annual results influenced by positive trends in growth regions 130
  • 6.50 Apr 08, 2016: Karolinska Development's portfolio company Promimic AB announces that its HAnano Surface improves implant-to-bone integration for PEEK implants 130
  • 6.51 Feb 25, 2016: Straumann And Anthogyr Announce Partnership 131
  • 6.52 Feb 15, 2016: 3-D Matrix: Announcement of Change of Representative Directors 131
  • 6.53 Jan 17, 2016: SurgaColl Technologies to Raise up to USD3.3 Million in Financing Round 132
  • 6.54 Jan 04, 2016: Salvin Dental Specialties Acquires Dental Biologics Business from Exactech 132
  • 6.55 Dec 09, 2015: Orthocell key scaffold patent granted in Canada 132

7 Appendix 133

  • 7.1 Methodology 133
  • 7.2 About GlobalData 136
  • 7.3 Contact Us 136
  • 7.4 Disclaimer 136

List of Tables

  • Table 1: Dental Biomaterials - Pipeline Products by Stage of Development 11
  • Table 2: Dental Biomaterials - Pipeline Products by Segment 12
  • Table 3: Dental Biomaterials - Pipeline Products by Territory 13
  • Table 4: Dental Biomaterials - Pipeline Products by Regulatory Path 14
  • Table 5: Dental Biomaterials - Pipeline Products by Estimated Approval Date 15
  • Table 6: Dental Biomaterials - Ongoing Clinical Trials 16
  • Table 7: Dental Biomaterials Companies - Pipeline Products by Stage of Development 17
  • Table 8: Dental Biomaterials - Pipeline Products by Stage of Development 19
  • Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 10: TDM-711 - Product Status 21
  • Table 11: TDM-711 - Product Description 22
  • Table 12: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 13: PARASORB Fleece - Product Status 23
  • Table 14: PARASORB Fleece - Product Description 24
  • Table 15: PARASORB Fleece Genta HD - Product Status 24
  • Table 16: PARASORB Fleece Genta HD - Product Description 25
  • Table 17: PARASORB Fleece HD - Product Status 25
  • Table 18: PARASORB Fleece HD - Product Description 26
  • Table 19: PARASORB RESODONT - Product Status 26
  • Table 20: PARASORB RESODONT - Product Description 27
  • Table 21: botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 22: Cerabone - Product Status 28
  • Table 23: Cerabone - Product Description 28
  • Table 24: Jason Collagen Fleece - Product Status 29
  • Table 25: Jason Collagen Fleece - Product Description 29
  • Table 26: Jason Membrane - Product Status 29
  • Table 27: Jason Membrane - Product Description 30
  • Table 28: maxresorb - Product Status 30
  • Table 29: maxresorb - Product Description 31
  • Table 30: maxresorb Inject - Product Status 31
  • Table 31: maxresorb Inject - Product Description 32
  • Table 32: mucoderm - Product Status 32
  • Table 33: mucoderm - Product Description 32
  • Table 34: perossal - Product Status 33
  • Table 35: perossal - Product Description 33
  • Table 36: botiss dental GmbH - Ongoing Clinical Trials Overview 34
  • Table 37: Cerabone - Radiographic Peri-implant Alveolar Bone Changes in Post-menopausal Osteoporotic Women 35
  • Table 38: CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 39: Dental Bone Graft - Product Status 36
  • Table 40: Dental Bone Graft - Product Description 36
  • Table 41: credentis AG Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 42: CUROLOX Scaffold - Product Status 37
  • Table 43: CUROLOX Scaffold - Product Description 37
  • Table 44: curasan AG Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 45: Cerasorb Foam Dental - Product Status 38
  • Table 46: Cerasorb Foam Dental - Product Description 39
  • Table 47: Cerasorb Paste Dental - Product Status 39
  • Table 48: Cerasorb Paste Dental - Product Description 39
  • Table 49: Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 50: NOVOSIS - DENT - Product Status 40
  • Table 51: NOVOSIS - DENT - Product Description 41
  • Table 52: Datum Dental Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 53: OSSIX VOLUMAX - Product Status 42
  • Table 54: OSSIX VOLUMAX - Product Description 43
  • Table 55: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 56: Artificial Teeth - Product Status 44
  • Table 57: Artificial Teeth - Product Description 44
  • Table 58: Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 59: Neofibrin - Product Status 45
  • Table 60: Neofibrin - Product Description 45
  • Table 61: Ironwood Material Science Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 62: GEMOSIL - Dental Implant - Product Status 46
  • Table 63: GEMOSIL - Dental Implant - Product Description 46
  • Table 64: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 65: MaxiBone - Product Status 47
  • Table 66: MaxiBone - Product Description 48
  • Table 67: MaxiGuide - Product Status 48
  • Table 68: MaxiGuide - Product Description 48
  • Table 69: Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 70: Dental Membrane - Product Status 49
  • Table 71: Dental Membrane - Product Description 49
  • Table 72: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 73: MD05-P Bone Graft Substitute Material - Product Status 50
  • Table 74: MD05-P Bone Graft Substitute Material - Product Description 51
  • Table 75: MD08 Injectable Paste - Product Status 51
  • Table 76: MD08 Injectable Paste - Product Description 51
  • Table 77: Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 78: Biocompatible Sealer - Product Status 52
  • Table 79: Biocompatible Sealer - Product Description 53
  • Table 80: Endodontic Sealer - Product Status 53
  • Table 81: Endodontic Sealer - Product Description 53
  • Table 82: Root Canal Sealer - Product Status 54
  • Table 83: Root Canal Sealer - Product Description 54
  • Table 84: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 85: Synthetic Mandible - Product Status 55
  • Table 86: Synthetic Mandible - Product Description 55
  • Table 87: Nobel Biocare Holding AG Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 88: Bone Inductive Implant - Product Status 56
  • Table 89: Bone Inductive Implant - Product Description 56
  • Table 90: NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 91: Bioengineered Resorbable Bone Graft - Dental - Product Status 57
  • Table 92: Bioengineered Resorbable Bone Graft - Dental - Product Description 57
  • Table 93: Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 94: Dental NovaOss - Product Status 58
  • Table 95: Dental NovaOss - Product Description 58
  • Table 96: Orthocell Limited Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 97: CelGro Collagen Scaffold - Product Status 59
  • Table 98: CelGro Collagen Scaffold - Product Description 60
  • Table 99: PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 100: BonyPid-500 - Product Status 61
  • Table 101: BonyPid-500 - Product Description 62
  • Table 102: PolyPid Ltd - Ongoing Clinical Trials Overview 63
  • Table 103: BonyPid-500 - PolyPid, Ltd. Pilot Study of the BonyPid-500 Bone Graft Substitute 64
  • Table 104: REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 105: Regenecure AMCA GBR Dental Membrane Implant - Product Status 65
  • Table 106: Regenecure AMCA GBR Dental Membrane Implant - Product Description 65
  • Table 107: REGENECURE, Ltd. - Ongoing Clinical Trials Overview 66
  • Table 108: Regenecure AMCA GBR Dental Membrane Implant - Horizontal Guided Bone Regeneration for Dental Implants Using Synthetic Membrane (Regenecures' AMCA GBR Dental Membrane) a Prospective Controlled Study 67
  • Table 109: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 110: Enhanced Bone Graft - Product Status 68
  • Table 111: Enhanced Bone Graft - Product Description 69
  • Table 112: Soft Tissue Control Implant - Product Status 69
  • Table 113: Soft Tissue Control Implant - Product Description 69
  • Table 114: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 115: DentaColl - Product Status 70
  • Table 116: DentaColl - Product Description 70
  • Table 117: SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 118: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Status 71
  • Table 119: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Description 71
  • Table 120: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 121: Dental Material - Product Status 72
  • Table 122: Dental Material - Product Description 72
  • Table 123: Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 124: Tigran Porous Titanium Granules - Alveolar Fillings - Product Status 73
  • Table 125: Tigran Porous Titanium Granules - Alveolar Fillings - Product Description 73
  • Table 126: Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 127: Inorganic Dental Cement - Product Status 74
  • Table 128: Inorganic Dental Cement - Product Description 75
  • Table 129: University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 130: Nanostructured Biomaterial - Product Status 76
  • Table 131: Nanostructured Biomaterial - Product Description 76
  • Table 132: Glossary 134

List of Figures

  • Figure 1: Dental Biomaterials - Pipeline Products by Stage of Development 11
  • Figure 2: Dental Biomaterials - Pipeline Products by Segment 12
  • Figure 3: Dental Biomaterials - Pipeline Products by Territory 13
  • Figure 4: Dental Biomaterials - Pipeline Products by Regulatory Path 14
  • Figure 5: Dental Biomaterials - Pipeline Products by Estimated Approval Date 15
  • Figure 6: Dental Biomaterials - Ongoing Clinical Trials 16
Back to Top